(Q36598957)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16987156%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

title

EFNS guidelines on management of narcolepsy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16987156%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

0 references

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16987156%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Karel Šonka

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16987156%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

author name string

M Billiard

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16987156%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

C Bassetti

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16987156%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

L Dolenc-Groselj

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16987156%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

G J Lammers

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16987156%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

G Mayer

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16987156%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

T Pollmächer

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16987156%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

P Reading

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16987156%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

EFNS Task Force

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16987156%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

publication date

1 October 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16987156%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Neurology

30 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16987156%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

volume

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16987156%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16987156%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

page(s)

1035-1048

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16987156%20AND%20SRC:MED&resulttype=core&format=json

Role of catecholamines in the modafinil and amphetamine induced wakefulness, a comparative pharmacological study in the cat.

30 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01473.X

The vigilance promoting drug modafinil increases dopamine release in the rat nucleus accumbens via the involvement of a local GABAergic mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01473.X

MAO-A and COMT polymorphisms and gene effects in narcolepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01473.X

Randomized trial of modafinil for the treatment of pathological somnolence in narcolepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01473.X

A randomized trial of the long-term, continued efficacy and safety of modafinil in narcolepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01473.X

Long-term efficacy and safety of modafinil (PROVIGIL((R))) for the treatment of excessive daytime sleepiness associated with narcolepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01473.X

Dosing Regimen Effects of Modafinil for Improving Daytime Wakefulness in Patients With Narcolepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01473.X

Effect of an oral contraceptive preparation containing ethinylestradiol and gestodene on CYP3A4 activity as measured by midazolam 1'-hydroxylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01473.X

Efficacy of gamma-hydroxybutyrate versus placebo in treating narcolepsy-cataplexy: double-blind subjective measures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01473.X

Mazindol in long-term treatment of narcolepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01473.X

Selegiline in the treatment of narcolepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01473.X

Sodium oxybate demonstrates long-term efficacy for the treatment of cataplexy in patients with narcolepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01473.X

Further evidence supporting the use of sodium oxybate for the treatment of cataplexy: a double-blind, placebo-controlled study in 228 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01473.X

Protriptyline: an effective agent in the treatment of the narcolepsy- cataplexy syndrome and hypersomnia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01473.X

Treatment of Cataplexy With Clomipramine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01473.X

Pharmacological aspects of human and canine narcolepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01473.X

Fluoxetine suppresses human cataplexy: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01473.X

The use of citalopram in resistant cataplexy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01473.X

Unusually prolonged rebound cataplexy after withdrawal of fluoxetine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01473.X

Obstructive sleep apnea syndrome induced by clonazepam in a narcoleptic patient with REM-sleep-behavior disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01473.X

A case of marital discord and secondary depression with attempted suicide resulting from REM sleep behavior disorder in a 35-year-old woman

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01473.X

Melatonin for treatment of REM sleep behavior disorder in neurologic disorders: results in 14 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01473.X

Periodic leg movements are not more prevalent in insomnia or hypersomnia but are specifically associated with sleep disorders involving a dopaminergic impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01473.X

Effects of bromocriptine on periodic limb movements in human narcolepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01473.X

Narcolepsy-cataplexy. II. Psychosocial consequences and associated psychopathology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01473.X

Narcolepsy and psychopathology: is there an association?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01473.X

Clinical efficacy of high-dose intravenous immunoglobulins near the onset of narcolepsy in a 10-year-old boy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01473.X